Georg Auzinger1, Julia Wendon. 1. Liver Intensive Care Unit, King's College Hospital, London, UK. georg.auzinger@kch.nhs.uk
Abstract
PURPOSE OF REVIEW: The mortality of acute liver failure remains unacceptably high and liver transplantation is the only effective treatment available to date. This review focuses on new research developments in the field and aims to provide a pragmatic organ-based treatment approach for liver failure patients requiring intensive care support. RECENT FINDINGS: The pathophysiological basis for cerebral edema formation in acute liver failure continued to be the focus of various investigations. In-vivo observations confirmed the link between ammonia, cerebral glutamine content and intracranial hypertension. The role of arterial ammonia as an important prognostic indicator formed the basis of prospective, observational studies. Reduced monocytic HLA-DR expression linked acute liver failure with poor prognosis, and the cerebral effects and side effects of vasoactive therapy with terlipressin were investigated with two studies showing contradictory results. SUMMARY: Despite increased knowledge of the pathophysiological events leading to organ dysfunction in acute liver failure, supportive treatment options remain limited in their efficacy and largely noncurative.
PURPOSE OF REVIEW: The mortality of acute liver failure remains unacceptably high and liver transplantation is the only effective treatment available to date. This review focuses on new research developments in the field and aims to provide a pragmatic organ-based treatment approach for liver failurepatients requiring intensive care support. RECENT FINDINGS: The pathophysiological basis for cerebral edema formation in acute liver failure continued to be the focus of various investigations. In-vivo observations confirmed the link between ammonia, cerebral glutamine content and intracranial hypertension. The role of arterial ammonia as an important prognostic indicator formed the basis of prospective, observational studies. Reduced monocytic HLA-DR expression linked acute liver failure with poor prognosis, and the cerebral effects and side effects of vasoactive therapy with terlipressin were investigated with two studies showing contradictory results. SUMMARY: Despite increased knowledge of the pathophysiological events leading to organ dysfunction in acute liver failure, supportive treatment options remain limited in their efficacy and largely noncurative.
Authors: Ulvi Demirel; Mehmet Yalniz; Cem Aygün; Cemal Orhan; Mehmet Tuzcu; Kazim Sahin; Ibrahim Hanifi Ozercan; Ibrahim Halil Bahçecioğlu Journal: Inflammation Date: 2012-08 Impact factor: 4.092
Authors: Dmitry Frank; Shiri Savir; Benjamin F Gruenbaum; Israel Melamed; Julia Grinshpun; Ruslan Kuts; Boris Knyazer; Alexander Zlotnik; Max Vinokur; Matthew Boyko Journal: J Vis Exp Date: 2020-04-28 Impact factor: 1.355
Authors: Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns Journal: Dtsch Arztebl Int Date: 2011-10-21 Impact factor: 5.594
Authors: Josef Prazak; Eva Laszikova; Tomas Pantoflicek; Ondrej Ryska; Eva Koblihova; Miroslav Ryska Journal: BMC Gastroenterol Date: 2013-06-08 Impact factor: 3.067